Age-specific mortality and immunity patterns of SARS-CoV-2

@article{ODriscoll2020AgespecificMA,
  title={Age-specific mortality and immunity patterns of SARS-CoV-2},
  author={Megan O’Driscoll and Gabriel Ribeiro Dos Santos and Lin Wang and Derek A. T. Cummings and Andrew S. Azman and Juliette Paireau and Arnaud Fontanet and Simon Cauchemez and Henrik Salje},
  journal={Nature},
  year={2020},
  volume={590},
  pages={140-145}
}
Estimating the size of the coronavirus disease 2019 (COVID-19) pandemic and the infection severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is made challenging by inconsistencies in the available data. The number of deaths associated with COVID-19 is often used as a key indicator for the size of the epidemic, but the observed number of deaths represents only a minority of all infections 1 , 2 . In addition, the heterogeneous burdens in nursing homes and the variable… 
Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies
TLDR
The first estimates of the age-specific rates at which individuals infected with SARS-CoV-2 develop severe and critical disease are presented using multi-country serology studies, together with public data on hospital admissions and mortality.
SARS-CoV-2 infections in 171 countries and over time
Understanding the dynamics of the COVID-19 pandemic, evaluating the efficacy of past and current control measures, and estimating vaccination needs, requires knowledge of the number of infections in
SARS-CoV-2 infections in 165 countries over time
  • S. Louca
  • Medicine
    International Journal of Infectious Diseases
  • 2021
An international comparison of age and sex dependency of COVID-19 deaths in 2020: a descriptive analysis
TLDR
An exponential increase with age is a good model to describe and analyze both COVID-19 and all-cause mortality above 40 years old, and males have an excess risk compared with women, which is less pronounced in the higher age groups.
Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany
TLDR
A comparison of effective IFRs with observed CFRs indicates that a substantial fraction of the time-dependent variability in observed mortality can be explained by changes in the age distribution of infections.
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
  • Action to beat coronavirusAction pour battre le co, P. Jha
  • Medicine
    medRxiv
  • 2021
TLDR
Self-collected DBS for antibody testing is a practicable strategy to monitor the ongoing second viral wave of SARS-CoV-2 and, eventually, vaccine-induced immunity among Canadian adults.
Estimating the evolution of effective infection fatality rates during the course of the COVID-19 pandemic in Germany.
TLDR
A comparison of estimated IFRs with observed CFRs indicates that a substantial fraction of the time-dependent variability in observed mortality can be explained by the evolving age distribution of infections.
Relative Burdens of the COVID-19, Malaria, Tuberculosis, and HIV/AIDS Epidemics in Sub-Saharan Africa
TLDR
Although all four epidemics continue, tuberculosis, HIV/AIDS, and malaria remain far greater health priorities based on their disease burdens, and resource diversion to COVID-19 poses a high risk of increasing the overall disease burden and causing net harm, thereby further increasing global inequities in health and life expectancy.
Immune response to COVID-19 in older adults
Comparing the age and sex trajectories of SARS-CoV-2 morbidity with other respiratory pathogens points to potential immune mechanisms.
Comparing age and sex differences in SARS-CoV-2 hospitalization and mortality with influenza and other health outcomes opens the way to generating hypotheses as to the underlying mechanisms, building
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 28 REFERENCES
Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
TLDR
While men and women have the same prevalence, men with COVID-19 are more at risk for worse outcomes and death, independent of age.
SARS-CoV-2 infection fatality risk in a nationwide seroepidemiological study
TLDR
The authors' IFR estimates for SARS-CoV-2 are substantially greater than IFR estimators for seasonal influenza, justifying the implementation of special public health measures.
Infection fatality risk for SARS-CoV-2: a nationwide seroepidemiological study in the non-institutionalized population of Spain
To estimate the range of the age- and sex-specific infection fatality risk (IFR) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on confirmed coronavirus disease 2019
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
TLDR
An estimation of the clinical severity of COVID-19, based on the data available so far, can help to inform the public health response during the ongoing SARS-CoV-2 pandemic.
Estimating the burden of SARS-CoV-2 in France
TLDR
France has been heavily affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and went into lockdown on 17 March 2020, and population immunity appears to be insufficient to avoid a second wave if all control measures are released at the end of the lockdown.
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
TLDR
The results show that major non-pharmaceutical interventions and lockdown in particular have had a large effect on reducing transmission and continued intervention should be considered to keep transmission of SARS-CoV-2 under control.
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
TLDR
Almost half of all school-aged children in Hong Kong were infected during the first wave of the pandemic H1N1 influenza A virus, and older adults aged 50-59 years had 9.5 and 66 times higher risks of ICU admission and death if infected, respectively.
Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset
TLDR
Serology testing provides an important complement to RNA testing in the later stages of illness for pathogenic-specific diagnosis and helpful information to evaluate the adapted immunity status of patients.
...
1
2
3
...